DNA replication licensing proteins: Saints and sinners in cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• DNA replication is a tightly regulated, all-or-none cellular process.
• The pre-replication complex, or DNA replication licensing complex (DNA replication LC), controls DNA replication initiation in eukaryotes.
• This complex comprises proteins like ORC, CDC6, CLF-1, and MCM family members.

Purpose of the Study:

• To review the role of DNA replication LC in cancer development and progression.
• To explore the potential of DNA replication LC as a diagnostic, prognostic, and therapeutic target in oncology.
• To elucidate the mechanisms behind aberrant DNA replication LC expression in various cancers.

Main Methods:

• Literature review of studies on DNA replication LC in cancer.
• Analysis of the impact of DNA replication LC on genomic stability and replication stress.
• Examination of therapeutic strategies targeting DNA replication LC, including siRNA and shRNA knockdown.

Main Results:

• High expression of DNA replication LC is a common hallmark in diverse cancers.
• Increased DNA replication LC promotes genomic instability by inducing replication stress.
• Reducing DNA replication LC activity enhances cancer cell sensitivity to chemotherapeutic agents.

Conclusions:

• DNA replication LC plays a dual role, acting as both a facilitator and a potential driver of cancer.
• Targeting DNA replication LC offers a promising strategy to improve chemotherapy efficacy.
• DNA replication LC holds significant clinical potential for cancer diagnosis, prognosis, and therapy.